To the editor
The validity of genetically altered mice as models for disease or for drug target identification relies on the reproducibility of behavioral test results. In a recent paper in Nature Neuroscience1, behavioral tests were described on α1(H101R) mice carrying a histidine-to-arginine point mutation in the α1 subunit of the GABAA receptor. An accompanying News and Views article2 discussed discrepancies between results of behavioral experiments for this study1 and our study of α1(H101R) mice3. The two lines of mice seemed to differ in their drug-induced behavior, although both had been constructed with the same point mutation. Now we report that these discrepencies were caused by differences in the behavioral protocols used by the two groups, not by differences in the mouse lines.
Both studies compared the behavioral effects of diazepam in wild-type and point-mutated α1(H101R) mice whose α1 GABAA receptor subtype was made insensitive to diazepam by a histidine-to-arginine substitution. We assessed the sedative action of diazepam on spontaneous motor activity of mice familiar with the testing environment3. Diazepam produced sedation in wild-type mice, as measured by the dose-dependent decrease in the extent of spontaneous motor activity, whereas diazepam failed to impair the spontaneous motor activity in α1(H101R) mice up to 30 mg per kg (ref. 3). These results led us to conclude that the sedative action of diazepam as measured by this protocol is mediated by α1 GABAA receptors. In contrast, McKernan and colleagues measured locomotor activity in mice exploring an unfamiliar environment1. The authors reported that diazepam (3 mg per kg orally) did not affect wild-type mice, but induced a significant increase in locomotor activity in the α1(H101R) mice. This has been interpreted as “paradoxical hyperactivity”2 and “reduction in neophobia”1 or “reduction in GABA-mediated neuronal inhibition”1. Following transfer to a new testing room 30 minutes before drug treatment, our α1(H101R) mice also exhibit hyperactivity (Fig. 1). These findings, which correspond to McKernan and colleagues' results1, suggest that the failure of diazepam to interact with α1 receptors is associated with a heightened behavioral arousal in response to stressors in α1(H101R) mice.
Another discrepancy between the studies was the reduced sensitivity of McKernan and colleagues' mutant mice1 to the ataxic effect of diazepam in locomotor performance during a rotarod test, in which the rod rotated at 18 revolutions per minute (rpm). In our test, at 2 rpm, motor coordination remained unaltered in the mutant as compared to wild-type mice3. However, when we conducted the rotarod test at a higher speed (4–40 rpm), the α1(H101R) mice remained insensitive to diazepam up to 10 mg per kg (Fig. 2). These findings are similar to those reported by McKernan and colleagues1.
Thus, under comparable test conditions, there are no apparent behavioral differences between the α1(H101R) mice generated by the two laboratories1,3. This shows that taking environmental and technical details of test procedures into account may help to resolve interlaboratory differences in results.
References
McKernan, R. M. et al. Nat. Neurosci. 3, 587–592 (2000).
Tecott, L. H. Nat. Neurosci. 3, 529–530 (2000).
Rudolph, U. et al. Nature 401, 796–800 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crestani, F., Martin, J., Möhler, H. et al. Resolving differences in GABAA receptor mutant mouse studies. Nat Neurosci 3, 1059 (2000). https://doi.org/10.1038/80553
Issue Date:
DOI: https://doi.org/10.1038/80553
This article is cited by
-
Trehalose ameliorates prodromal non-motor deficits and aberrant protein accumulation in a rotenone-induced mouse model of Parkinson’s disease
Archives of Pharmacal Research (2022)
-
Neural Basis of Benzodiazepine Reward: Requirement for α2 Containing GABAA Receptors in the Nucleus Accumbens
Neuropsychopharmacology (2014)
-
50 years of hurdles and hope in anxiolytic drug discovery
Nature Reviews Drug Discovery (2013)
-
The GABAergic deficit hypothesis of major depressive disorder
Molecular Psychiatry (2011)
-
Environmental standardization: cure or cause of poor reproducibility in animal experiments?
Nature Methods (2009)